Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

Role of the Proprotein Convertase Subtilisin/Kexin Type 5 Gene and the Proprotein Convertase 5 - Endothelial Lipase System in High-density Lipoproteins (HDL) Metabolism: Relevance to HDL Remodeling and Atherosclerotic Cardiovascular Disease Development

FY 2008-09

Summary
Cholesterol accumulations in vascular cells of coronary arteries are the main cause of cardiovascular disease. The high-density lipoproteins (HDL) found in blood are known to carry the "good cholesterol" and help prevent heart disease by removing excess cholesterol from cells. However, low levels of plasma HDL-cholesterol (HDL-C) are strongly associated with an increased risk of coronary artery disease (CAD). The causes of low HDL-C are poorly understood and few genetic studies have been able to identify defects in genes governing the HDL metabolism as responsible for various forms of HDL deficiencies. Cardiovascular homeostasis is dependent on the proprotein convertases, a family of proteinases involved in the activation/inaction of vascular events and in the cellular proteolysis of secretory proteins, allowing them to play numerous roles in different metabolic pathways. The proprotein convertase 5 encoding the proprotein convertase subtilisin/kexin type 5 (PCSK5) gene is known to inactivate endothelial lipase, vascular enzyme critical in modulating HDL-C levels, implicating it in the regulation of HDL metabolism. Its link however to HDL deficiency remains to be explored. Recently we have discovered that mutations in the PCSK5 gene can lower HDL-C levels. We thus hypothesize that genetic variations in the PCSK5 gene influence CAD risk and that the PC5 protein is implicated in regulation of lipid levels in mammals. This project aims to understand the mechanisms of function and the molecular interactions between the PC5 protein and the EL enzyme, both in humans and in mice, in order to determine their effect on HDL-C metabolism These results will shed new light on the potential contribution of the PCSK5 gene and its protein PC5 in HDL deficiency and heart disease.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
184713
Name
Iatan Iulia
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Role of the Proprotein Convertase Subtilisin/Kexin Type 5 Gene and the Proprotein Convertase 5 - Endothelial Lipase System in High-density Lipoproteins (HDL) Metabolism: Relevance to HDL Remodeling and Atherosclerotic Cardiovascular Disease Development
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Association Studies; Cardiovascular Disease; Cell Culture; Genotyping; Haplotypes; Hdl Human Genetics; High-Density Lipoprotein; Lipid Biochemistry; Proprotein Convertase Subtilisin/Kexin 5 Gene
Abstract
Cholesterol accumulations in vascular cells of coronary arteries are the main cause of cardiovascular disease. The high-density lipoproteins (HDL) found in blood are known to carry the "good cholesterol" and help prevent heart disease by removing excess cholesterol from cells. However, low levels of plasma HDL-cholesterol (HDL-C) are strongly associated with an increased risk of coronary artery disease (CAD). The causes of low HDL-C are poorly understood and few genetic studies have been able to identify defects in genes governing the HDL metabolism as responsible for various forms of HDL deficiencies. Cardiovascular homeostasis is dependent on the proprotein convertases, a family of proteinases involved in the activation/inaction of vascular events and in the cellular proteolysis of secretory proteins, allowing them to play numerous roles in different metabolic pathways. The proprotein convertase 5 encoding the proprotein convertase subtilisin/kexin type 5 (PCSK5) gene is known to inactivate endothelial lipase, vascular enzyme critical in modulating HDL-C levels, implicating it in the regulation of HDL metabolism. Its link however to HDL deficiency remains to be explored. Recently we have discovered that mutations in the PCSK5 gene can lower HDL-C levels. We thus hypothesize that genetic variations in the PCSK5 gene influence CAD risk and that the PC5 protein is implicated in regulation of lipid levels in mammals. This project aims to understand the mechanisms of function and the molecular interactions between the PC5 protein and the EL enzyme, both in humans and in mice, in order to determine their effect on HDL-C metabolism These results will shed new light on the potential contribution of the PCSK5 gene and its protein PC5 in HDL deficiency and heart disease.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Iatan, Iulia
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McGill University - $105,000 Grant (2008-09) | Canada Spends